Texas Heart Institute
Texas Heart Institute (THI), founded by world-renowned cardiovascular surgeon Dr. Denton A. Cooley in 1962, is a nonprofit organization dedicated to delivering the future of cardiovascular health through exceptional patient care, discovery, and a commitment to learning.
2020
Texas Heart Institute
Menopause vs. Manopause: Why Have the CVD Rates of Death Been on the Decline? Is Menapause a Risk Factor?
FEATURING
Stephanie Coulter
- 233 views
- April 20, 2021
- 1
Texas Heart Institute
Male Menopause: Does Testosterone Therapy Increase Cardiovascular Risk?
FEATURING
Stephanie Coulter
- 558 views
- April 20, 2021
Texas Heart Institute
Status of Women Cardiovascular Surgeons in the US Today
FEATURING
Ourania Preventza
- 2 views
- April 9, 2021
Texas Heart Institute
TAVR vs. SAVR: What Can Be Learned from Recent Prohibitive, Intermediate, Low Risk and Durability Clinical Trials?
FEATURING
Zvonimir Krajcer
- 610 views
- April 9, 2021
- 4
Texas Heart Institute
Venous Arterialisation as Treatment for CLTI: What Are the Two Different Ways to Perform the Procedure?
FEATURING
Miguel Montero-Baker
- 1,807 views
- April 20, 2021
- 9
Texas Heart Institute
Cryptogenic Stroke: Is PFO Implicated?
FEATURING
R. David Fish
- 7 views
- April 20, 2021
Texas Heart Institute
Cryptogenic Stroke: When Do We Close A PFO?
FEATURING
R. David Fish
- 17 views
- April 20, 2021
Texas Heart Institute
Cardio-Oncology: Who Are the Cancer Patients at Risk For Developing Cardiac Dysfunction?
FEATURING
Juan Carlos Plana
- 5 views
- April 20, 2021
Texas Heart Institute
What's New in Atrial Fibrillation
FEATURING
Mehdi Razavi
- 19 views
- April 20, 2021
Texas Heart Institute
Updates on the CABANA and AMAZE Trials: What Is the Efficacy of Catheter Ablation vs. Antiarrhythmic Drug Therapy Among Patients With Atrial Fibrillation? Does the Left Atrial Appendage Occluder Help in the Management of Permanent A-Fib?
FEATURING
Mehdi Razavi
- 915 views
- April 20, 2021
- 3
Texas Heart Institute
CAD Assessment: What Are the Risk Formulas? What Are the Associated Tests Used to Assess Risk?
FEATURING
Eduardo Hernandez
- 1 view
- April 22, 2021
Texas Heart Institute
Coronary Artery Disease and the Use of Aspirin: What Is the Efficacy of Use for Primary Prevention?
FEATURING
Eduardo Hernandez
- 977 views
- April 22, 2021
- 4
Texas Heart Institute
Triglyceride Reduction for CV Risk: What Do We Know About the Association With ASCVD Events?
FEATURING
Salim Virani
- 5 views
- April 22, 2021
Texas Heart Institute
Insights into Triglyceride Reduction: What Do the Treatment Guidelines Tell Us and Why?
FEATURING
Salim Virani
- 389 views
- April 22, 2021
- 2
Texas Heart Institute
Triglyceride Lowering Therapies: What Have We Recently Learned? What Is Coming Down the Pipeline?
FEATURING
Salim Virani
- 1,024 views
- April 22, 2021
- 6
Texas Heart Institute
Heart Failure in Women: What Is the Epidemiology?
FEATURING
Jerry D. Estep
- 7 views
- April 20, 2021
Texas Heart Institute
Women and Heart Failure: What Does the Evidence Show for Differences Between the Sexes?
FEATURING
Jerry D. Estep
- 12 views
- April 20, 2021
Texas Heart Institute
Heart Failure and Women: What Are the Devices and Sex Specific Medications?
FEATURING
Jerry D. Estep
- 25 views
- April 20, 2021
Texas Heart Institute
The Latest Advances in TAVR: How to Significantly Reduce Conduction Disturbances?
FEATURING
Zvonimir Krajcer,
Hemal Gada
- 408 views
- April 9, 2021
- 3
Texas Heart Institute
Current Status of TAVR: How Has Site Preference Affected Outcomes? What Are the Unmet Needs?
FEATURING
Zvonimir Krajcer,
Vinod Thourani
- 215 views
- April 9, 2021
- 3